Internal Medicine, Hematology & Oncology · Athens, GA
NPI
1952567505
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3320 Old Jefferson Rd Bldg 800
Athens, GA, 30607
Phone (706) 353-2990
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
119,441 services
Medicare patients, 2024
692
Average age 75
Drug cost, 2024
$5.0M
1,583 prescriptions
Company payments, 2025
$2,152
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kuang S Chang was code J9271 (injection, pembrolizumab, 1 mg), 10,800 times for 12 patients. In total Kuang S Chang billed 119,441 services in 202 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,800 | 12 | $44.72 | $483K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,720 | 12 | $39.62 | $385K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 7,492 | 63 | $15.71 | $118K |
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 24 | $20.83 | $57K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,925 | 19 | $6.19 | $12K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,782 | 46 | $0.09 | $160 |
| 99214 Office E&M - Established | Office | 1,353 | 459 | $91.58 | $124K |
| 85025 Blood Count | Office | 960 | 356 | $7.60 | $7,294 |
| 36415 Venipuncture Blood Collection | Office | 932 | 369 | $8.63 | $8,042 |
| 96367 Intravenous Infusion, Hydration | Office | 405 | 72 | $20.21 | $8,185 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 396 | 18 | $0.07 | $28.69 |
| 88185 Surgical Pathology Examination | Office | 391 | 15 | $15.88 | $6,209 |
| 96413 Chemotherapy Administration | Office | 330 | 87 | $90.24 | $30K |
| 96372 Injection Administration | Office | 325 | 101 | $10.48 | $3,408 |
| 83615 Clinical Chemistry | Office | 292 | 166 | $5.92 | $1,729 |
By year: 2022 $3.4M for 168,790 services; 2023 $3.4M for 164,736 services; 2024 $3.2M for 119,441 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 960 | 356 | $7.60 | $7,294 |
| 36415 Venipuncture Blood Collection | 932 | 369 | $8.63 | $8,042 |
| 88185 Surgical Pathology Examination | 391 | 15 | $15.88 | $6,209 |
| 83615 Clinical Chemistry | 292 | 166 | $5.92 | $1,729 |
| 84550 Clinical Chemistry | 288 | 164 | $4.43 | $1,276 |
| 80053 Clinical Chemistry | 265 | 159 | $10.35 | $2,743 |
| 83883 Clinical Chemistry | 162 | 47 | $13.33 | $2,159 |
| 82784 Immunoassay | 153 | 35 | $9.11 | $1,394 |
| 82728 Clinical Chemistry | 121 | 108 | $13.36 | $1,617 |
| 83550 Clinical Chemistry | 121 | 108 | $8.57 | $1,037 |
Medicare prescription drug claims, 2024
In 2024, the drug Kuang S Chang prescribed most often to Medicare patients was Eliquis (Apixaban), with 89 prescriptions and refills. In total Kuang S Chang wrote 1,583 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 89 | 117 | 20 | $67K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 71 | 71 | 35 | $1,813 |
| Anastrozole Generic | 67 | 194 | 28 | $1,172 |
| Tamoxifen Citrate Generic | 56 | 136 | 14 | $929 |
| Hydroxyurea Generic | 47 | 121 | 18 | $1,701 |
| Procrit Epoetin Alfa | 38 | 38 | Under 11 | $16K |
| Acyclovir Generic | 36 | 66 | 11 | $550 |
| Pantoprazole Sodium Generic | 35 | 81 | 17 | $267 |
| Neulasta Onpro Pegfilgrastim | 33 | 33 | Under 11 | $203K |
| Xgeva Denosumab | 32 | 51 | Under 11 | $100K |
| Imbruvica Ibrutinib | 32 | 32 | Under 11 | $494K |
| Gabapentin Generic | 31 | 51 | 14 | $564 |
| Furosemide Generic | 30 | 30 | Under 11 | $21.49 |
| Xtandi Enzalutamide | 29 | 29 | Under 11 | $321K |
| Prednisone Generic | 28 | 40 | 16 | $121 |
Brand drugs: 624 claims; generic drugs: 959 claims; opioid claims: 134.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kuang S Chang $2,152 ($2,152 in general payments such as food, travel and fees) from 38 companies. The largest payer was Abbvie Inc. with $289.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $289 |
| Pfizer Inc. PFE | 12 | $238 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $147 |
| Merck Sharp & Dohme LLC MRK | 4 | $104 |
| GlaxoSmithKline, LLC. GSK | 4 | $90.68 |
| Eisai Inc. 4523.T | 4 | $84.02 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $75.91 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $75.19 |
| Gilead Sciences, Inc. GILD | 3 | $72.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.